Procardia xl and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is reported as a side effect among people who take Procardia xl (nifedipine), especially for people who are female, 50-59 old, also take Coumadin, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Dry skin when taking Procardia xl. It is created by eHealthMe based on reports of 6,048 people who have side effects when taking Procardia xl from the FDA, and is updated regularly.

What is Procardia xl?

Procardia xl has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 6,209 Procardia xl users. Check the latest studies of Procardia xl.

What is Dry skin?

Dry skin is found to be associated with 1,993 drugs and 2,353 conditions by eHealthMe. Check the latest studies of Dry skin.

On Jul, 13, 2026

6,048 people reported to have side effects when taking Procardia xl.
Among them, 37 people (0.61%) have Dry skin.

Among these 37 people:

What is the gender of people who have Dry skin when taking Procardia xl? *

female: 75.68 %
male: 24.32 %

What is the age of people who have Dry skin when taking Procardia xl? *

What are other drugs people take besides Procardia xl? *

What are other side effects people have besides Dry skin? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 22 people, 59.46%
Pain In Extremity: 21 people, 56.76%
Pain: 20 people, 54.05%
Itching: 17 people, 45.95%
Skin Exfoliation (removal of the oldest dead skin cells): 15 people, 40.54%
Skin Induration (an abnormally hard spot or area on the skin): 15 people, 40.54%
Oedema Peripheral (superficial swelling): 15 people, 40.54%
Stress And Anxiety: 14 people, 37.84%
Skin Tightness: 14 people, 37.84%
Rashes (redness): 14 people, 37.84%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 9 people, 24.32%
Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 13.51%
Venous Pressure Increased: 4 people, 10.81%
Renal Cancer Stage Iv (the tumour has spread to areas beyond gerota's fascia and extends into the adrenal gland on the same side of the body as the tumour, possibly to lymph nodes, but not to other parts of the body): 3 people, 8.11%
High Blood Cholesterol: 3 people, 8.11%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.41%
Diabetes: 2 people, 5.41%
Essential Hypertension (primary hypertension): 2 people, 5.41%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.41%
Hypersensitivity: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Procardia xl and have Dry skin?

- Check whether Dry skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Procardia xl:

Procardia xl (6,209 reports)

Dry skin treatments and more:

Dry skin (131,310 reports)

Browse all side effects of Procardia xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry skin:

Dry skin (1,993 drugs)

Browse all the conditions that are associated with Dry skin:

Dry skin (2,353 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Procardia xl) and Procardia xl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.